GRNA — Greenlight Biosciences Holdings PBC Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $45.43m
- $37.72m
- $6.78m
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital
U.S. STOCKS ON THE MOVE-Arlington Asset Investment, Redwoods, GreenLight Biosciences
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital
Brief: Greenlight Biosciences Enters Into Definitive Merger Agreement With Consortium Led By Fall Line Endurance Fund For Go-Private Transaction
Brief: Greenlight Biosciences Announces Q1 2023 Financial Results, Highlights Recent Company Progress
Brief: Greenlight Biosciences Q1 net loss USD 28.469 million
Brief: Greenlight Biosciences Holdings Confirms Receipt Of Indication Of Interest From Fall Line
Brief: Greenlight Biosciences Announces Fourth Quarter And Full Year 2022 Financial Results
Brief: Greenlight Biosciences Reports Q4 Net Loss Per Share of 0.26
U.S. STOCKS ON THE MOVE-Tesla, Peloton, Thermo Fisher Scientific
GreenLight Biosciences up on approval for COVID vaccine trial in Rwanda
Brief: Greenlight Biosciences Receives Approval To Initiate Phase I/II Clinical Trial Of Covid-19 mRNA Vaccine Candidate
Brief: Greenlight Biosciences And Epivax Therapeutics Collaborates To Develop Personalized Cancer Vaccines
Brief: Greenlight Biosciences Announces Third Quarter 2022 Financial Results
GreenLight Biosciences down on restructuring plan
Brief: Greenlight Biosciences To Reduce Company’S Workforce By Approximately 25%